Cite
HARVARD Citation
Pascal, L. et al. (n.d.). Stereotactic ablative radiotherapy (SABR) for early stage, non-small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC). Lung cancer. pp. S33-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pascal, L. et al. (n.d.). Stereotactic ablative radiotherapy (SABR) for early stage, non-small cell lung cancer (NSCLC): two year clinical outcome data from the Oxford Cancer Centre (OCC). Lung cancer. pp. S33-. [Online].